Acorda Therapeutics is an American biotechnology company that focuses on developing therapies that improve the lives of people with neurological disorders. The company was founded in 1995 and is headquartered in Ardsley, New York. Acorda's main product is Ampyra, which is used to improve walking in patients with multiple sclerosis. The company also has several other products in development for the treatment of Parkinson's disease, migraine, and other neurological disorders.